Pioglitazone improves virological response to peginterferon α-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance - Concepedia

Concepedia

Publication | Open Access

Pioglitazone improves virological response to peginterferon α-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance

DOI Full Paper Access

87

Citations

18

References

2009

Year

Mahmoud Khattab, Mohammed Emad, A. Abdelaleem, Mohammed Eslam, Rabab Atef, Yehia Shaker, Lamia Hamdy

Liver International

Abstract

A combination of pioglitazone, Peg-IFN-alpha-2b and ribavirin increased RVR, SVR and decreased IR, compared with patients given Peg-IFN plus ribavirin without an increase in adverse events.

References

	Year	Citations

Page 1